On September 27, 2019, the Kyoto City Venture Business Connoisseur Committee held its final review and approved our business plan for “Development of regenerative medicine products using novel human neural stem cells “OligoGenie”” as rank A.

■https://www.astem.or.jp/smes-venture-mekiki/company/139/